Tiziana Life Sciences announces that it has been notified that Gabriele Cerrone, its Chairman and Acting CEO, purchased 45,000 common shares at 66c per share, bringing his total holding to 38,685,737 common shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TLSA:
- Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
- Tiziana Life Sciences announces purchase of common shares by chairman
- Tiziana Life Sciences Highlighted in Forbes Article
- Tiziana Life Sciences announces FORBES article highlighting foralumab
- Tiziana Life Sciences announces publication in PNAS on foralumab